OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
2026-07-15
原文 →
找到 2 篇相关文章
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
Sandstone's Series A was led by Lightspeed Partners, with participation from Sequoia.